Regulation of Gut Microbiota on Immune Reconstitution in Patients With Acquired Immunodeficiency Syndrome
Open Access
- 27 October 2020
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 11, 594820
Abstract
Human immunodeficiency virus type 1 (HIV-1) infection of CD4+ T cells in the gut plays an insidious role in acquired immunodeficiency syndrome (AIDS) pathogenesis. Host immune function is closely related to gut microbiota. Changes in the gut microbiota cause a different immune response. Previous studies revealed that HIV-1 infection caused changes in gut microbiota, which induced immune deficiency. HIV-1 infection results in an abnormal composition and function of the gut microbiota, which may disrupt the intestinal epithelial barrier and microbial translocation, leading to long-term immune activation, including inflammation and metabolic disorders. At the same time, an abnormal gut microbiota also hinders the effect of antiviral therapy and affects the immune reconstruction of patients. However, studies on the impact of the gut microbiota on immune reconstitution in patients with HIV/AIDS are still limited. In this review, we focus on changes in the gut microbiota caused by HIV infection, as well as the impact and regulation of the gut microbiota on immune function and immune reconstitution, while we also discuss the potential impact of probiotics/prebiotics and fecal bacteria transplantation (FMT) on immune reconstitution.Keywords
Funding Information
- National Natural Science Foundation of China (81660094)
This publication has 132 references indexed in Scilit:
- Diversity, stability and resilience of the human gut microbiotaNature, 2012
- Structure, function and diversity of the healthy human microbiomeNature, 2012
- Commensal bacteria–derived signals regulate basophil hematopoiesis and allergic inflammationNature Medicine, 2012
- Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the “COPA” pilot randomized trialMucosal Immunology, 2011
- Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiotaProceedings of the National Academy of Sciences, 2010
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008
- HIV infection and the gastrointestinal immune systemMucosal Immunology, 2007
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006
- An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune SystemCell, 2005